CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
LipoLife systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03800563
NCT03800563N/ACompleted
CompareCT.gov

The Safety and Efficacy of Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System

Alma Lasers·interventional·Posted Jan 11, 2019·Updated Oct 25, 2022

In Brief

A clinical study evaluating LipoLife system for Laser Assisted Liposuction. Completed, enrolled 20 participants across 2 sites in 2 countries.

Detailed Summary

Multi-center, prospective, open-label, single arm study. The study aims to evaluate the safety and efficacy of Laser Assisted Liposuction procedure performed with the LipoLife system. The study will include twenty (20) eligible subjects, that are willing to undergo abdominal or outer thighs laser-assisted liposuction. Five to twenty (5-20) subjects out of this study group should also be eligible for facial fat grafting. Follow up visits to evaluate study endpoints will take place at 1, 3 and 6 months after the surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLaser Assisted Liposuction
CountriesIsrael, United States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJan 11, 2019
Enrollment StartNov 6, 2018
Primary CompletionSep 10, 2019
Study CompletionMay 20, 2020
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 7.5 years ago

Interventions

LipoLife systemdevice

Abdominal/ Outer thighs Laser Assisted Liposuction. Five to twenty subjects out of the study group will also undergo facial fat grafting.